GM
Gilfoyle Management Portfolio holdings
AUM
$25K
1 Year Est. Return
–
AUM
$19.4K
AUM Growth
+$11.9K
(+158%)
Holding
5
Top Buys
| 1 | +$4.84K | |
| 2 | +$2.4K | |
| 3 | +$1.59K | |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.35K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$741 |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 25% |
| 2 | Consumer Discretionary | 12.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$6.22B
| $4.84K | 25% |
+100
|
|
||
|
2
iShares Core S&P 500 ETF
IVV
$656B
| $4.5K | 23.25% |
10
+3
|
|
||
3
ARK Innovation ETF
ARKK
$9.05B
| $4.29K | 22.16% |
100
+37
|
|
||
|
4
Invesco QQQ Trust
QQQ
$381B
| $3.33K | 17.21% |
9
+2
|
|
||
5
Tesla
TSLA
$1.43T
| $2.4K | 12.38% |
+10
|
|